184
Participants
Start Date
October 31, 2014
Primary Completion Date
August 31, 2015
Study Completion Date
January 31, 2016
1 drop of 0.375% SYL040012 (bamosiran)
1 drop of 0.750% SYL040012 (bamosiran)
1 drop of 1.125% SYL040012 (bamosiran)
1 drop of 1.5% SYL040012 (bamosiran)
1 drop of 0.5 % timolol maleate
East Tallin Central Hospital, Tallinn
Hospital de Jerez, Jerez de la Frontera
Eye Clinic Dr. Krista Turman, Tallinn
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario Clínico San Carlos, Madrid
Eye Care Centers Management, Inc (Clayton Eye Center), Morrow
Clinica Universidad Navarra, Pamplona
Complejo Hospitalario de Pontevedra, Pontevedra
University Clinic Magdeburg, Magdeburg
Taustin Eye Center, Louisville
Instituto de Oftalmobiología Aplicada, Valladolid
Hospital Universitario Miguel Servet, Zaragoza
Tartu University Hospital, Tartu
Universitaetsklinikum Freiburg, Freiburg im Breisgau
Klinikum der Universität München, München
Sall Research Medical Center, Artesia
University Hospital Regensburg, Regensburg
North Bay Eye Associates, Petaluma
Universitätsklinikum Münster, Münster
Hospital de Torrevieja, Torrevieja
Hospital Clinic, Barcelona
Sylentis, S.A.
INDUSTRY